Shots

Gilead Sciences' Harvoni can cure hepatitis C, but the drug costs a fortune. Lloyd Fox/Baltimore Sun/TNS via Getty Images hide caption

Generic drugmaker Mylan is one of the companies reported to be the subject of a Justice Department investigation into pricing of generic drugs. Jeff Swensen/Getty Images hide caption

Community Health Options founders COO Robert Hillman (left) and CEO Kevin Lewis seen in 2013 when the co-op began offering coverage. Gordon Chibroski/Portland Press Herald/Getty Images hide caption

After several prominent safety problems with medical devices in hospitals emerged, the Food and Drug Administration inspected 17 hospitals across the country in late 2015 to assess their compliance with reporting regulations. Congressional Quarterly/CQ-Roll Call, Inc./Getty Images hide caption

A patient with Crohn's disease receives an IV infusion of Remicade, or infliximab. Dr P. Marazzi/Science Source hide caption

Shela Bryan of Hull, Ga., is looking for a new health insurance policy but has been stunned by the prices. Steven Bush/Courtesy of Shela Bryan hide caption

Biotrial, a French company that runs clinical studies, has opened a facility in Newark, N.J. Chris Cooper/Biotrial hide caption

Sarepta Therapeutics was awarded a voucher for a fast-track drug review by the Food and Drug Administration when the company's medicine for Duchenne muscular dystropy was approved Sept. 19. Now Sarepta is looking to sell the voucher to the highest bidder. Mick Wiggins/Ikon Images/Getty Images hide caption

A job reviewing drug applications at the Food and Drug Administration can be the springboard for a career in industry. Andrew Harnik/AP hide caption